536 related articles for article (PubMed ID: 14559017)
1. Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel.
Ruan G; Feng SS
Biomaterials; 2003 Dec; 24(27):5037-44. PubMed ID: 14559017
[TBL] [Abstract][Full Text] [Related]
2. Chitin/PLGA blend microspheres as a biodegradable drug delivery system: a new delivery system for protein.
Mi FL; Shyu SS; Lin YM; Wu YB; Peng CK; Tsai YH
Biomaterials; 2003 Dec; 24(27):5023-36. PubMed ID: 14559016
[TBL] [Abstract][Full Text] [Related]
3. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs.
Dong Y; Feng SS
Biomaterials; 2004 Jun; 25(14):2843-9. PubMed ID: 14962562
[TBL] [Abstract][Full Text] [Related]
4. Controlled delivery of taxol from poly(ethylene glycol)-coated poly(lactic acid) microspheres.
Das GS; Rao GHR ; Wilson RF; Chandy T
J Biomed Mater Res; 2001 Apr; 55(1):96-103. PubMed ID: 11426403
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of fenofibrate-loaded PLA-PEG microspheres.
Ren J; Yu X; Ren T; Hong H
J Mater Sci Mater Med; 2007 Aug; 18(8):1481-7. PubMed ID: 17387589
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of biodegradable poly(l-lactide)/poly(ethylene glycol) microcapsules containing erythromycin by emulsion solvent evaporation technique.
Park SJ; Kim SH
J Colloid Interface Sci; 2004 Mar; 271(2):336-41. PubMed ID: 14972610
[TBL] [Abstract][Full Text] [Related]
7. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
8. A method using biodegradable polylactides/polyethylene glycol for drug release with reduced initial burst.
Huang YY; Chung TW; Tzeng TW
Int J Pharm; 1999 May; 182(1):93-100. PubMed ID: 10332078
[TBL] [Abstract][Full Text] [Related]
9. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
[TBL] [Abstract][Full Text] [Related]
10. Influences of preparation conditions on particle size and DNA-loading efficiency for poly(DL-lactic acid-polyethylene glycol) microspheres entrapping free DNA.
Liu Y; Deng X
J Control Release; 2002 Sep; 83(1):147-55. PubMed ID: 12220846
[TBL] [Abstract][Full Text] [Related]
11. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.
Zhang Z; Feng SS
Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085
[TBL] [Abstract][Full Text] [Related]
12. Self-assembled filomicelles prepared from polylactide/poly(ethylene glycol) block copolymers for anticancer drug delivery.
Jelonek K; Li S; Wu X; Kasperczyk J; Marcinkowski A
Int J Pharm; 2015 May; 485(1-2):357-64. PubMed ID: 25796125
[TBL] [Abstract][Full Text] [Related]
13. Oligo(lactic acid)n-Paclitaxel Prodrugs for Poly(ethylene glycol)-block-poly(lactic acid) Micelles: Loading, Release, and Backbiting Conversion for Anticancer Activity.
Tam YT; Gao J; Kwon GS
J Am Chem Soc; 2016 Jul; 138(28):8674-7. PubMed ID: 27374999
[TBL] [Abstract][Full Text] [Related]
14. Polyethylenglycol-co-poly-D,L-lactide copolymer based microspheres: preparation, characterization and delivery of a model protein.
Dorati R; Genta I; Tomasi C; Modena T; Colonna C; Pavanetto F; Perugini P; Conti B
J Microencapsul; 2008 Aug; 25(5):330-8. PubMed ID: 18465305
[TBL] [Abstract][Full Text] [Related]
15. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
Jackson JK; Hung T; Letchford K; Burt HM
Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
[TBL] [Abstract][Full Text] [Related]
16. Development and characterization of CyA-loaded poly(lactic acid)-poly(ethylene glycol)PEG micro- and nanoparticles. Comparison with conventional PLA particulate carriers.
Gref R; Quellec P; Sanchez A; Calvo P; Dellacherie E; Alonso MJ
Eur J Pharm Biopharm; 2001 Mar; 51(2):111-8. PubMed ID: 11226817
[TBL] [Abstract][Full Text] [Related]
17. PEG-b-PLA micelles and PLGA-b-PEG-b-PLGA sol-gels for drug delivery.
Cho H; Gao J; Kwon GS
J Control Release; 2016 Oct; 240():191-201. PubMed ID: 26699425
[TBL] [Abstract][Full Text] [Related]
18. Preparation and modification of N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a protein carrier.
Xu Y; Du Y; Huang R; Gao L
Biomaterials; 2003 Dec; 24(27):5015-22. PubMed ID: 14559015
[TBL] [Abstract][Full Text] [Related]
19. Controlled drug release system based on cyclodextrin-conjugated poly(lactic acid)-b-poly(ethylene glycol) micelles.
He Q; Wu W; Xiu K; Zhang Q; Xu F; Li J
Int J Pharm; 2013 Feb; 443(1-2):110-9. PubMed ID: 23328682
[TBL] [Abstract][Full Text] [Related]
20. Effects of material hydrophobicity on physical properties of polymeric microspheres formed by double emulsion process.
Ruan G; Feng SS; Li QT
J Control Release; 2002 Dec; 84(3):151-60. PubMed ID: 12468218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
